search
Back to results

Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus

Primary Purpose

COVID, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Tele-interventions related to diabetes management and mental well-being
Sponsored by
Federal University of Rio Grande do Sul
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for COVID focused on measuring COVID-19, Diabetes Mellitus, Glycemic control, Tele-Intervention, Mental well-being

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 1 diabetes mellitus or type 2 diabetes mellitus;
  • Age greater than or equal to 18 years;
  • HbA1c assessed in January, February or March 2020;
  • Availability to receive weekly phone calls

Exclusion Criteria:

  • Any severe cognitive limitation that prevents the necessary interaction to carry out this study (advanced dementia, deafness, dysarthria, aphasia);
  • Do not present a telephone record in an electronic medical record;

Sites / Locations

  • Hospital de Clínicas de Porto Alegre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Tele-Intervention

Usual Care

Arm Description

Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period

Participants will receive the usual care

Outcomes

Primary Outcome Measures

Variation in HbA1c levels
Variation in HbA1c levels comparatively between groups after the period of social distancing measures.

Secondary Outcome Measures

COVID-19 infection
Confirmation of coronavirus infection by rapid test
Variation in lipid profile
Comparison of the lipid profile of the last year with the lipid profile after the intervention between the groups.
Variation in blood pressure levels
Comparison of the blood pressure level of the last consultation with the pressure after the intervention between the groups.
Comparison of emotional distress associated with the routine of living with diabetes after intervention between groups
Evaluation of emotional distress associated with the routine of living with diabetes - B-PAID (Brazilian Problem Areas In Diabetes Scale)
Comparison of eating disorders between groups
Evaluation of eating disorders - EAT - 26 SCALE (Teste de Atitudes Alimentares)
Comparison of adherence to the proposed clinical treatment between groups
Evaluation of adherence to the proposed clinical treatment - SCI R (Self-Care Inventory - revised)
Comparison of minor psychiatric disorders between groups
Evaluation of minor psychiatric disorders - SRQ 20 (Self Report Questionnaire)
Comparison of sleep pattern changes between groups
Evaluation of sleep pattern changes - MSQ (Mini Sleep Questionnaire)

Full Information

First Posted
April 7, 2020
Last Updated
October 11, 2020
Sponsor
Federal University of Rio Grande do Sul
search

1. Study Identification

Unique Protocol Identification Number
NCT04344210
Brief Title
Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus
Official Title
Impact of Tele-Interventions During the COVID-19 Pandemic on Glycemic Control and Attitude Toward the Disease in Patients With Diabetes Mellitus - A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
April 17, 2020 (Actual)
Primary Completion Date
September 20, 2020 (Actual)
Study Completion Date
September 20, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Rio Grande do Sul

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
INTRODUCTION In critical situations, such as the current COVID 19 pandemic, themes of fear, uncertainty and stigmatization are common and constitute barriers to appropriate medical and mental health interventions. These challenges, when faced by those who live with a chronic disease, such as diabetes mellitus (DM), can negatively influence quality of life and adherence to treatment, compromising the control of the disease. OBJECTIVES The present study aims to investigate the effectiveness of a tele-intervention during the COVID-19 pandemic in improving glycemic control, lipid profile, blood pressure levels and parameters of medication adherence, mental well-being and sleep quality in patients with type 1 DM and type 2 DM. METHODS A randomized clinical trial will be carried out with patients with a previous diagnosis of type 1 DM and type 2 DM, who are registered at the Hospital de Clínicas de Porto Alegre (HCPA). Inclusion criteria will be age greater than or equal to 18 years, collection of HbA1c in the HCPA laboratory in January, February or March 2020 and availability to receive weekly phone calls. Patients will be randomized, stratified by type of diabetes, in two groups: G1: participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the social distancing period ; G2: participants will receive the usual care. The primary outcome assessed will be the variation in HbA1c levels comparatively between groups, with or without a tele-guided strategy, after four months of social distancing (or as long as the recommendation of social distancing measures remains). Secondary outcomes will include experiencing confirmation of COVID-19 infection, variation in lipid profile, blood pressure levels and variation in parameters of emotional distress related to diabetes, eating disorders, medication adherence, symptoms minor psychiatric disorders and altered sleep patterns, which will be evaluated with specific and validated scales. According to the sample calculation, 150 patients will be included in the study (92 with type 2 DM and 58 with type 1 DM). Analysis by intention to treat will be performed separately for patients with type 1 DM and with type 2 DM. SCHEDULE The proposed experiment will start immediately after approval of this project by the research ethics committee. The duration of the proposed intervention is 4 months (or as long as the recommendation of social distancing measures remains. This means that the study may be completed before or after that period, based on national recommendations for social distancing in Brazil), with a data analysis plan and publication of the results until September 2020.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Keywords
COVID-19, Diabetes Mellitus, Glycemic control, Tele-Intervention, Mental well-being

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized in two groups: G1: participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period ; G2: participants will receive the usual care.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
149 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tele-Intervention
Arm Type
Experimental
Arm Description
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants will receive the usual care
Intervention Type
Behavioral
Intervention Name(s)
Tele-interventions related to diabetes management and mental well-being
Intervention Description
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
Primary Outcome Measure Information:
Title
Variation in HbA1c levels
Description
Variation in HbA1c levels comparatively between groups after the period of social distancing measures.
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Secondary Outcome Measure Information:
Title
COVID-19 infection
Description
Confirmation of coronavirus infection by rapid test
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Variation in lipid profile
Description
Comparison of the lipid profile of the last year with the lipid profile after the intervention between the groups.
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Variation in blood pressure levels
Description
Comparison of the blood pressure level of the last consultation with the pressure after the intervention between the groups.
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Comparison of emotional distress associated with the routine of living with diabetes after intervention between groups
Description
Evaluation of emotional distress associated with the routine of living with diabetes - B-PAID (Brazilian Problem Areas In Diabetes Scale)
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Comparison of eating disorders between groups
Description
Evaluation of eating disorders - EAT - 26 SCALE (Teste de Atitudes Alimentares)
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Comparison of adherence to the proposed clinical treatment between groups
Description
Evaluation of adherence to the proposed clinical treatment - SCI R (Self-Care Inventory - revised)
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Comparison of minor psychiatric disorders between groups
Description
Evaluation of minor psychiatric disorders - SRQ 20 (Self Report Questionnaire)
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)
Title
Comparison of sleep pattern changes between groups
Description
Evaluation of sleep pattern changes - MSQ (Mini Sleep Questionnaire)
Time Frame
4 months (or as long as the recommendation of social distancing measures remains)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 1 diabetes mellitus or type 2 diabetes mellitus; Age greater than or equal to 18 years; HbA1c assessed in January, February or March 2020; Availability to receive weekly phone calls Exclusion Criteria: Any severe cognitive limitation that prevents the necessary interaction to carry out this study (advanced dementia, deafness, dysarthria, aphasia); Do not present a telephone record in an electronic medical record;
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90620-170
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
35595850
Citation
Alessi J, Becker AS, Amaral B, de Oliveira GB, Franco DW, Knijnik CP, Kobe GL, de Brito A, de Carvalho TR, Telo GH, Schaan BD, Telo GH. Type 1 diabetes and the challenges of emotional support in crisis situations: results from a feasibility study of a multidisciplinary teleintervention. Sci Rep. 2022 May 20;12(1):8526. doi: 10.1038/s41598-022-12227-z.
Results Reference
derived
PubMed Identifier
35197493
Citation
Alessi J, Becker AS, Amaral B, de Oliveira GB, Franco DW, Knijnik CP, Kobe GL, de Brito A, de Carvalho TR, Telo GH, Schaan BD, Telo GH. Type 1 diabetes and the challenges of emotional support in crisis situations: results from a randomized clinical trial of a multidisciplinary teleintervention. Sci Rep. 2022 Feb 23;12(1):3086. doi: 10.1038/s41598-022-07005-w.
Results Reference
derived

Learn more about this trial

Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus

We'll reach out to this number within 24 hrs